Logo image of AMSF

AMERISAFE INC (AMSF) Stock Fundamental Analysis

USA - NASDAQ:AMSF - US03071H1005 - Common Stock

44.71 USD
+0.64 (+1.45%)
Last: 9/18/2025, 8:00:00 PM
44.71 USD
0 (0%)
After Hours: 9/18/2025, 8:00:00 PM
Fundamental Rating

4

AMSF gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 146 industry peers in the Insurance industry. AMSF has only an average score on both its financial health and profitability. AMSF is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

AMSF had positive earnings in the past year.
In the past year AMSF had a positive cash flow from operations.
AMSF had positive earnings in each of the past 5 years.
In the past 5 years AMSF always reported a positive cash flow from operatings.
AMSF Yearly Net Income VS EBIT VS OCF VS FCFAMSF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

AMSF has a better Return On Assets (4.37%) than 81.51% of its industry peers.
AMSF has a Return On Equity of 18.99%. This is amongst the best in the industry. AMSF outperforms 88.36% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.30%, AMSF is in the better half of the industry, outperforming 76.03% of the companies in the same industry.
AMSF had an Average Return On Invested Capital over the past 3 years of 4.78%. This is in line with the industry average of 4.47%.
Industry RankSector Rank
ROA 4.37%
ROE 18.99%
ROIC 4.3%
ROA(3y)4.74%
ROA(5y)4.96%
ROE(3y)20.1%
ROE(5y)19.3%
ROIC(3y)4.78%
ROIC(5y)4.81%
AMSF Yearly ROA, ROE, ROICAMSF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

AMSF has a better Profit Margin (16.64%) than 86.99% of its industry peers.
AMSF's Profit Margin has declined in the last couple of years.
The Operating Margin of AMSF (19.73%) is better than 76.03% of its industry peers.
AMSF's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 19.73%
PM (TTM) 16.64%
GM N/A
OM growth 3Y-3.47%
OM growth 5Y-8.09%
PM growth 3Y-5.13%
PM growth 5Y-6.1%
GM growth 3YN/A
GM growth 5YN/A
AMSF Yearly Profit, Operating, Gross MarginsAMSF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AMSF is destroying value.
The number of shares outstanding for AMSF has been reduced compared to 1 year ago.
Compared to 5 years ago, AMSF has less shares outstanding
The debt/assets ratio for AMSF has been reduced compared to a year ago.
AMSF Yearly Shares OutstandingAMSF Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
AMSF Yearly Total Debt VS Total AssetsAMSF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

AMSF has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC0.49
WACC8.7%
AMSF Yearly LT Debt VS Equity VS FCFAMSF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
AMSF Yearly Current Assets VS Current LiabilitesAMSF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2

3. Growth

3.1 Past

The earnings per share for AMSF have decreased by -9.16% in the last year.
The earnings per share for AMSF have been decreasing by -11.34% on average. This is quite bad
The Revenue has decreased by -1.18% in the past year.
The Revenue has been decreasing by -3.91% on average over the past years.
EPS 1Y (TTM)-9.16%
EPS 3Y-3.68%
EPS 5Y-11.34%
EPS Q2Q%-8.62%
Revenue 1Y (TTM)-1.18%
Revenue growth 3Y-0.45%
Revenue growth 5Y-3.91%
Sales Q2Q%6.93%

3.2 Future

Based on estimates for the next years, AMSF will show a decrease in Earnings Per Share. The EPS will decrease by -5.27% on average per year.
The Revenue is expected to grow by 2.58% on average over the next years.
EPS Next Y-6.86%
EPS Next 2Y-4.22%
EPS Next 3Y-5.27%
EPS Next 5YN/A
Revenue Next Year-0.09%
Revenue Next 2Y2.58%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AMSF Yearly Revenue VS EstimatesAMSF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
AMSF Yearly EPS VS EstimatesAMSF Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.79, which indicates a rather expensive current valuation of AMSF.
Based on the Price/Earnings ratio, AMSF is valued a bit more expensive than the industry average as 64.38% of the companies are valued more cheaply.
When comparing the Price/Earnings ratio of AMSF to the average of the S&P500 Index (27.41), we can say AMSF is valued slightly cheaper.
The Price/Forward Earnings ratio is 19.34, which indicates a rather expensive current valuation of AMSF.
AMSF's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. AMSF is more expensive than 69.18% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AMSF to the average of the S&P500 Index (22.88), we can say AMSF is valued inline with the index average.
Industry RankSector Rank
PE 18.79
Fwd PE 19.34
AMSF Price Earnings VS Forward Price EarningsAMSF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

AMSF's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, AMSF is valued a bit more expensive than the industry average as 73.29% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 107.22
EV/EBITDA 12.98
AMSF Per share dataAMSF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The decent profitability rating of AMSF may justify a higher PE ratio.
AMSF's earnings are expected to decrease with -5.27% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.22%
EPS Next 3Y-5.27%

3

5. Dividend

5.1 Amount

AMSF has a Yearly Dividend Yield of 3.44%. Purely for dividend investing, there may be better candidates out there.
AMSF's Dividend Yield is a higher than the industry average which is at 3.43.
Compared to an average S&P500 Dividend Yield of 2.38, AMSF pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.44%

5.2 History

The dividend of AMSF decreases each year by -0.15%.
AMSF has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-0.15%
Div Incr Years0
Div Non Decr Years0
AMSF Yearly Dividends per shareAMSF Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

170.90% of the earnings are spent on dividend by AMSF. This is not a sustainable payout ratio.
The Dividend Rate of AMSF has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP170.9%
EPS Next 2Y-4.22%
EPS Next 3Y-5.27%
AMSF Yearly Income VS Free CF VS DividendAMSF Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AMSF Dividend Payout.AMSF Dividend Payout, showing the Payout Ratio.AMSF Dividend Payout.PayoutRetained Earnings

AMERISAFE INC

NASDAQ:AMSF (9/18/2025, 8:00:00 PM)

After market: 44.71 0 (0%)

44.71

+0.64 (+1.45%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)10-21 2025-10-21/amc
Inst Owners101.96%
Inst Owner Change-1.33%
Ins Owners1.33%
Ins Owner Change6.7%
Market Cap849.04M
Analysts76
Price Target55.42 (23.95%)
Short Float %1.43%
Short Ratio2.45
Dividend
Industry RankSector Rank
Dividend Yield 3.44%
Yearly Dividend4.47
Dividend Growth(5Y)-0.15%
DP170.9%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-12 2025-09-12 (0.39)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.59%
Min EPS beat(2)-3.64%
Max EPS beat(2)-3.53%
EPS beat(4)1
Avg EPS beat(4)-1.23%
Min EPS beat(4)-3.64%
Max EPS beat(4)4.89%
EPS beat(8)2
Avg EPS beat(8)-3.53%
EPS beat(12)4
Avg EPS beat(12)-1.11%
EPS beat(16)6
Avg EPS beat(16)-3.99%
Revenue beat(2)1
Avg Revenue beat(2)-2.23%
Min Revenue beat(2)-7.3%
Max Revenue beat(2)2.84%
Revenue beat(4)2
Avg Revenue beat(4)-2.05%
Min Revenue beat(4)-7.3%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)-1.19%
Revenue beat(12)6
Avg Revenue beat(12)-0.82%
Revenue beat(16)8
Avg Revenue beat(16)-0.6%
PT rev (1m)-1.21%
PT rev (3m)-3.55%
EPS NQ rev (1m)0.61%
EPS NQ rev (3m)1.83%
EPS NY rev (1m)1.17%
EPS NY rev (3m)0.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.88%
Revenue NY rev (3m)1.27%
Valuation
Industry RankSector Rank
PE 18.79
Fwd PE 19.34
P/S 2.8
P/FCF 107.22
P/OCF 93.91
P/B 3.2
P/tB 3.2
EV/EBITDA 12.98
EPS(TTM)2.38
EY5.32%
EPS(NY)2.31
Fwd EY5.17%
FCF(TTM)0.42
FCFY0.93%
OCF(TTM)0.48
OCFY1.06%
SpS15.95
BVpS13.98
TBVpS13.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.37%
ROE 18.99%
ROCE 5.36%
ROIC 4.3%
ROICexc 4.5%
ROICexgc 5.13%
OM 19.73%
PM (TTM) 16.64%
GM N/A
FCFM 2.61%
ROA(3y)4.74%
ROA(5y)4.96%
ROE(3y)20.1%
ROE(5y)19.3%
ROIC(3y)4.78%
ROIC(5y)4.81%
ROICexc(3y)4.99%
ROICexc(5y)5.03%
ROICexgc(3y)5.72%
ROICexgc(5y)5.69%
ROCE(3y)5.96%
ROCE(5y)5.99%
ROICexcg growth 3Y2.96%
ROICexcg growth 5Y-5.98%
ROICexc growth 3Y2.27%
ROICexc growth 5Y-6.79%
OM growth 3Y-3.47%
OM growth 5Y-8.09%
PM growth 3Y-5.13%
PM growth 5Y-6.1%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 118.86%
Cap/Sales 0.37%
Interest Coverage 250
Cash Conversion 14.89%
Profit Quality 15.71%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC8.7%
ROIC/WACC0.49
Cap/Depr(3y)92.38%
Cap/Depr(5y)99.43%
Cap/Sales(3y)0.38%
Cap/Sales(5y)0.37%
Profit Quality(3y)45.41%
Profit Quality(5y)52.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-9.16%
EPS 3Y-3.68%
EPS 5Y-11.34%
EPS Q2Q%-8.62%
EPS Next Y-6.86%
EPS Next 2Y-4.22%
EPS Next 3Y-5.27%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.18%
Revenue growth 3Y-0.45%
Revenue growth 5Y-3.91%
Sales Q2Q%6.93%
Revenue Next Year-0.09%
Revenue Next 2Y2.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.35%
EBIT growth 3Y-3.9%
EBIT growth 5Y-11.68%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-65.27%
FCF growth 3Y-13.99%
FCF growth 5Y-21.39%
OCF growth 1Y-62.17%
OCF growth 3Y-13.98%
OCF growth 5Y-21.04%